Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AXIS IIa - Treatment With AX200 for Acute Ischemic Stroke

NCT00132470 is registered in ClinicalTrials.gov with Axaron Bioscience AG as lead sponsor.

NCT NCT00132470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00132470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AXIS IIa - Treatment With AX200 for Acute Ischemic Stroke
Lead sponsor
Axaron Bioscience AG
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2004
Completion date
March 31, 2007
Enrollment
42
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral stroke